SCHEMBL24790557

SCHEMBL24790557

COC(=O)Nc1ncnn2c([C@]3(C#N)O[C@H](CO)[C@H]4OC(C)(C)O[C@H]43)ccc12

nearest known ligand 0.52

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ TMPRSS2 O15393 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24304929 0.92 TMPRSS2 (0.49) TMPRSS2
SCHEMBL30931404 0.89 TMPRSS2 (0.47) TMPRSS2
SCHEMBL24917812 0.89 TMPRSS2 (0.47) TMPRSS2
SCHEMBL24917400 0.88 TMPRSS2 (0.59) TMPRSS2
SCHEMBL30931394 0.88 TMPRSS2 (0.59) TMPRSS2
SCHEMBL30931389 0.87 TMPRSS2 (0.49) TMPRSS2
SCHEMBL24917033 0.87 TMPRSS2 (0.49) TMPRSS2
SCHEMBL25917292 0.84 TMPRSS2 (0.44) TMPRSS2
SCHEMBL24917355 0.84 TMPRSS2 (0.44) TMPRSS2
SCHEMBL25909436 0.84 TMPRSS2 (0.43) TMPRSS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022265964-A1 ORALLY-BIOAVAILABLE NUCLEOSIDE ANALOGS VenatoRx Pharmaceuticals, Inc. (US) 2022-12-22 — — WO disclosed
Send feedback